Clinical Trial Update: Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)

View source ↗

Summary

A completed clinical trial evaluates how smoking, benzodiazepine use, and obesity influence the severity of obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Snippet

Sponsor: Astes | Conditions: Obstructive Sleep Apnea, Obesity | Status: COMPLETED